ONMD

SEC source: 0001493152-26-046908 · ownership.xml · nonDerivative · entry 1

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 896,840

F1 · kind: On October 9, 2026, the issuer entered into a subscription agreement with the reporting person for a $250,000 investment in the issuer.

F2 · price: The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date.

SEC source: 0001493152-26-046909 · ownership.xml · nonDerivative · entry 1

Kosasa Thomas · CIK 0001989846 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,983,573

F1 · kind: On October 7, 2026, the issuer entered into a subscription agreement with the reporting person for a $750,000 investment in the issuer.

F2 · price: The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date.

SEC source: 0001493152-26-046652 · ownership.xml · nonDerivative · entry 3

Green Aaron · CIK 0001990275 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 247,971

F3 · kind: Represents shares sold by the reporting person to cover tax obligations upon the vesting and settlement of RSUs.

SEC source: 0001493152-26-046652 · ownership.xml · nonDerivative · entry 2

Green Aaron · CIK 0001990275 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 249,638

F3 · kind: Represents shares sold by the reporting person to cover tax obligations upon the vesting and settlement of RSUs.

SEC source: 0001493152-26-046648 · ownership.xml · nonDerivative · entry 5

Golden Robert Lawrence · CIK 0001585507 · Director · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,291

F5 · kind: Represents shares sold by the reporting person to cover tax obligations upon the vesting and settlement of RSUs.

SEC source: 0001493152-26-046648 · ownership.xml · nonDerivative · entry 4

Golden Robert Lawrence · CIK 0001585507 · Director · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,291

F5 · kind: Represents shares sold by the reporting person to cover tax obligations upon the vesting and settlement of RSUs.

SEC source: 0001493152-26-046648 · ownership.xml · nonDerivative · entry 3

Golden Robert Lawrence · CIK 0001585507 · Director · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,291

F5 · kind: Represents shares sold by the reporting person to cover tax obligations upon the vesting and settlement of RSUs.

SEC source: 0001493152-26-042642 · ownership.xml · nonDerivative · entry 1

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,923,267

F1 · kind: On September 10, 2026, the issuer entered into a subscription agreement with the reporting person for a $90,000 investment in the issuer.

F2 · price: The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date.

SEC source: 0001493152-26-036660 · ownership.xml · nonDerivative · entry 1

Kosasa Thomas · CIK 0001989846 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,538,150

F1 · kind: On July 30, 2026, the issuer entered into a subscription agreement with the reporting person for a $1,000,000 investment in the issuer.

F2 · price: The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date.

SEC source: 0001493152-26-046648 · ownership.xml · nonDerivative · entry 2

Golden Robert Lawrence · CIK 0001585507 · Director · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,791

F2 · shares: Represents RSUs granted pursuant to contractor arrangements with the reporting person. The RSUs vest with respect to 1/3 of the shares on the first anniversary of the vesting start date of January 1, 2026, with the remaining RSUs vesting in equal quarterly installments on the last day of each fiscal quarter over 24 months thereafter, subject to the reporting person's continued service with the issuer through each vesting date.

F3 · shares: Each RSU represents the contingent right to receive one share of the issuer's common stock.

SEC source: 0001493152-26-046652 · ownership.xml · nonDerivative · entry 1

Green Aaron · CIK 0001990275 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 254,638

F1 · shares: Represents Restricted Stock Units ("RSUs") granted to the reporting person under the OneMedNet Corporation 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the issuer's common stock. The RSUs vest with respect to 1/3 of the shares on the first anniversary of the vesting start date of January 1, 2026, with the remaining RSUs vesting in equal quarterly installments on the last day of each fiscal quarter over 24 months thereafter, subject to the reporting person's continued service with the issuer through each vesting date.

F2 · shares: All share amounts and share prices shown in this report have been adjusted to reflect the 1-for-10 reverse stock split by the issuer on September 29, 2026.

SEC source: 0001493152-26-029878 · ownership.xml · nonDerivative · entry 1

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,780,410

F1 · kind: On June 23, 2026, the issuer entered into a subscription agreement with the reporting person for a $100,000 investment in the issuer.

SEC source: 0001493152-26-029880 · ownership.xml · nonDerivative · entry 1

Green Aaron · CIK 0001990275 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,896,375

F1 · kind: Represents an open market purchase in a single transaction.

SEC source: 0001493152-26-028988 · ownership.xml · nonDerivative · entry 1

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,621,680

F1 · kind: On June 16, 2026, the issuer entered into a subscription agreement with the reporting person for a $100,000 investment in the issuer.

SEC source: 0001493152-26-028793 · ownership.xml · nonDerivative · entry 2

Green Aaron · CIK 0001990275 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,859,725

SEC source: 0001493152-26-028585 · ownership.xml · nonDerivative · entry 1

Kosasa Thomas · CIK 0001989846 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,088,874

F1 · kind: On June 12, 2026, the issuer entered into a subscription agreement with the reporting person for a $100,000 investment in the issuer.

F2 · price: The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date.

SEC source: 0001493152-26-028793 · ownership.xml · nonDerivative · entry 1

Green Aaron · CIK 0001990275 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,841,023

F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.5463 to $0.5625, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in the footnotes of this report.

SEC source: 0001493152-26-024642 · ownership.xml · nonDerivative · entry 1

Kosasa Thomas · CIK 0001989846 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,930,144

F1 · kind: On May 18, 2026, the issuer entered into a subscription agreement with the reporting person for a $250,000 investment in the issuer.

F2 · price: The shares were valued at the volume-weighted average price (VWAP) of the issuer for the 10 trading days immediately prior to the purchase date.

SEC source: 0001493152-26-018860 · ownership.xml · nonDerivative · entry 2

Kosasa Thomas · CIK 0001989846 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,661,327

F3 · kind: On April 23, 2026, the issuer entered into a subscription agreement with the reporting person for a $250,000 investment in the issuer.

F2 · price: The shares were valued at the volume-weighted average price for the 10 trading days immediately prior to the applicable purchase date.

SEC source: 0001493152-26-018861 · ownership.xml · nonDerivative · entry 2

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,449,266

F2 · kind: Represents shares issued in lieu of prior cash compensation owed to the reporting person. The shares were valued at the volume-weighted average price for the 10 trading days immediately prior to the issuance date.

SEC source: 0001493152-26-018861 · ownership.xml · nonDerivative · entry 1

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,229,837

F1 · kind: On April 1, 2026, the issuer entered into a subscription agreement with the reporting person for a $750,000 investment in the issuer. The shares were valued at the volume-weighted average price for the 10 trading days immediately prior to the purchase date.

SEC source: 0001493152-26-018860 · ownership.xml · nonDerivative · entry 1

Kosasa Thomas · CIK 0001989846 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,380,429

F1 · kind: On February 6, 2026, the issuer entered into a subscription agreement with the reporting person for a $500,000 investment in the issuer.

F2 · price: The shares were valued at the volume-weighted average price for the 10 trading days immediately prior to the applicable purchase date.

SEC source: 0001493152-26-046648 · ownership.xml · nonDerivative · entry 1

Golden Robert Lawrence · CIK 0001585507 · Director · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,791

F1 · shares: Represents restricted stock units ("RSUs") granted pursuant to contractor arrangements with the reporting person. The RSUs vest in full on December 31, 2026, subject to the terms of Section 7.2.2 of the Consulting Agreement, dated January 1, 2026, between the issuer and Mr. Golden.

F3 · shares: Each RSU represents the contingent right to receive one share of the issuer's common stock.

F4 · balance_after: All share amounts and share prices shown in this report have been adjusted to reflect the 1-for-10 reverse stock split by the issuer on September 29, 2026.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 22

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,326,223

F21 · shares: Represents RSUs granted as director compensation under the 2022 Plan for board service in fiscal year 2025. The RSUs vest on December 31, 2025, subject to the reporting person's continued service with the issuer through the vesting date.

SEC source: 0001493152-25-025275 · ownership.xml · nonDerivative · entry 7

Golden Robert Lawrence · CIK 0001585507 · Director · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 547,905

F6 · shares: Represents RSUs granted as director compensation under the 2022 Plan for board service in fiscal year 2025. The RSUs vest on December 31, 2025, subject to the reporting person's continued service with the issuer through the vesting date.

SEC source: 0001493152-25-025276 · ownership.xml · nonDerivative · entry 4

Green Aaron · CIK 0001990275 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,930,425

F4 · shares: Represents RSUs granted as director compensation under the 2022 Plan for board service in fiscal year 2025. The RSUs vest on December 31, 2025, subject to the reporting person's continued service with the issuer through the vesting date.

SEC source: 0001493152-25-025272 · ownership.xml · nonDerivative · entry 2

McCraw Sherry Coonse · CIK 0002084961 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,342

F2 · shares: Represents RSUs granted as director compensation under the 2022 Plan for board service in fiscal year 2025. The RSUs vest on December 31, 2025, subject to the reporting person's continued service with the issuer through the vesting date.

SEC source: 0001493152-25-025277 · ownership.xml · nonDerivative · entry 10

Kosasa Thomas · CIK 0001989846 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,785,191

F7 · shares: Represents RSUs granted as director compensation under the 2022 Plan for board service in fiscal year 2025. The RSUs vest on December 31, 2025, subject to the reporting person's continued service with the issuer through the vesting date.

SEC source: 0001493152-25-025271 · ownership.xml · nonDerivative · entry 3

Clarke Jair · CIK 0001939502 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,485

F3 · shares: Represents RSUs granted as director compensation under the 2022 Plan for board service in fiscal year 2025. The RSUs vest on December 31, 2025, subject to the reporting person's continued service with the issuer through the vesting date.

SEC source: 0001493152-25-025273 · ownership.xml · nonDerivative · entry 3

Zeinfeld Andrew B · CIK 0001361934 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 381,525

F3 · shares: Represents RSUs granted as director compensation under the 2022 Plan for board service in fiscal year 2025. The RSUs vest on December 31, 2025, subject to the reporting person's continued service with the issuer through the vesting date.

SEC source: 0001493152-25-025274 · ownership.xml · nonDerivative · entry 9

Casaburi Eric · CIK 0001990853 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,475

F2 · shares: Represents RSUs granted as director compensation under the 2022 Plan for board service in fiscal year 2025. The RSUs vest on December 31, 2025, subject to the reporting person's continued service with the issuer through the vesting date.

SEC source: 0001493152-25-025270 · ownership.xml · nonDerivative · entry 1

Alleyne Kenneth · CIK 0002084760 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,219

F1 · shares: Represents restricted stock units ("RSUs") granted as director compensation under the OneMedNet Corporation 2022 Equity Incentive Plan for board service in fiscal year 2025. Each RSU represents the contingent right to receive one share of the issuer's common stock. The RSUs vest on December 31, 2025, subject to the reporting person's continued service with the issuer through the vesting date.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 21

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,281,223

F20 · shares: Represents restricted stock units ("RSUs") granted under the OneMedNet Corporation 2022 Equity Incentive Plan (the "2022 Plan") as employment compensation. RSUs vest as to one-third (1/3) of the RSUs on the first anniversary of the vesting start date of January 1, 2025, with the remaining RSUs vesting thereafter in equal quarterly installments on the last day of each fiscal quarter over the subsequent two (2) years, provided that the recipient remains in continuous service through each vesting date.

SEC source: 0001493152-25-025275 · ownership.xml · nonDerivative · entry 6

Golden Robert Lawrence · CIK 0001585507 · Director · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 502,905

F5 · shares: Represents RSUs granted pursuant to contractor arrangements with the reporting person. The RSUs vest in full on December 31, 2025, subject to the terms of Section 7.2.2 of the Consulting Agreement, dated August 30, 2024, between the issuer and Mr. Golden.

SEC source: 0001493152-25-025275 · ownership.xml · nonDerivative · entry 5

Golden Robert Lawrence · CIK 0001585507 · Director · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 469,572

F4 · shares: Represents RSUs granted pursuant to contractor arrangements with the reporting person. The RSUs vest with respect to 1/3 of the shares on the first anniversary of the vesting start date of January 1, 2025, with the remaining RSUs vesting in equal quarterly installments on the last day of each fiscal quarter over 24 months thereafter, subject to the reporting person's continued service with the issuer through each vesting date.

SEC source: 0001493152-25-025276 · ownership.xml · nonDerivative · entry 3

Green Aaron · CIK 0001990275 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,885,425

F3 · shares: Represents RSUs granted under the 2022 Plan as employment compensation for fiscal years 2024 and 2025. The RSUs vest with respect to 47% of the RSUs on the first anniversary of the vesting start date of January 1, 2025, with the remaining RSUs vesting on the last day of each fiscal quarter as follows: (i) 33% of the RSUs in equal quarterly installment during fiscal year 2026, and (ii) 20% of the RSUs in equal quarterly installment during fiscal year 2027, subject to the reporting person's continued service with the issuer through each vesting date.

SEC source: 0001493152-25-029137 · ownership.xml · nonDerivative · entry 2

Green Aaron · CIK 0001990275 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,804,103

F1 · kind: Represents shares sold solely to cover tax withholding obligations upon vesting and settlement of restricted stock unit awards.

SEC source: 0001493152-25-029137 · ownership.xml · nonDerivative · entry 1

Green Aaron · CIK 0001990275 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,865,658

F1 · kind: Represents shares sold solely to cover tax withholding obligations upon vesting and settlement of restricted stock unit awards.

SEC source: 0001493152-25-025274 · ownership.xml · nonDerivative · entry 8

Casaburi Eric · CIK 0001990853 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,475

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 20

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,081,223

F19 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.03 to $1.04, inclusive.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 19

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,079,973

F18 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.01 to $1.05, inclusive.

SEC source: 0001493152-25-025277 · ownership.xml · nonDerivative · entry 9

Kosasa Thomas · CIK 0001989846 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,740,191

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 18

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,062,773

F17 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.91 to $0.96, inclusive.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 17

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,057,073

F16 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.93 to $0.99, inclusive.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 16

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,056,673

F15 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.88 to $0.92, inclusive.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 15

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,055,423

F14 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.89 to $0.94, inclusive.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 14

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,054,723

F13 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.84 to $0.90, inclusive.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 13

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,052,623

F12 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.84 to $0.92, inclusive.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 12

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,040,813

F11 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.77 to $0.86, inclusive.

SEC source: 0001493152-25-025279 · ownership.xml · nonDerivative · entry 11

Yu Jeffrey · CIK 0001991132 · Director · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,029,143

F10 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.83 to $0.88, inclusive.